IMAImageneBio, Inc.同业对比
ImageneBio, Inc. 与SIC 2836 行业的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 | 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IMA本股 | $58M#6 | — | 0.4x#2 | 72.6x#4 | -77.1%#6 | -24.0%#8 | -6056.4%#5 | -31.9%#3 | — | — | -39.7%#6 | — |
| CSBR | $76M#1 | — | 19.6x#8 | 1.3x#1 | 4.4%#1 | -125.0%#13 | -1.9%#1 | -0.0%#1 | — | — | — | — |
| KLRS | $73M#2 | — | 1.3x#5 | 440.0x#6 | — | 37.2%#2 | -27970.9%#6 | -75.3%#5 | — | — | -31.0%#5 | — |
| ELOX | $72M#3 | 5.0x#1 | 1.6x#6 | — | -100.0%#7 | -90.7%#11 | — | -12.9%#2 | — | — | — | — |
| LONA | $65M#4 | — | 1.9x#7 | — | — | -9.3%#4 | — | -315.5%#9 | — | — | 79.6%#3 | — |
| INKT | $59M#5 | — | — | — | — | -15.9%#7 | — | — | — | — | -19.0%#4 | — |
| BKHAU | $53M#7 | — | — | — | — | -30.6%#9 | — | — | — | — | 133.8%#1 | 96.2%#2 |
| TVGN | $50M#8 | — | — | — | — | -91.4%#12 | — | — | — | — | -81.7%#12 | — |
| BKHA | $49M#9 | — | — | — | — | -30.6%#9 | — | — | — | — | 126.3%#2 | 104.1%#1 |
| TIL | $49M#10 | — | 0.5x#3 | — | -100.0%#7 | 3.7%#3 | — | -66.5%#4 | — | — | -66.5%#10 | — |
| SCLX | $46M#11 | — | — | 1.5x#2 | -46.5%#4 | -413.8%#14 | -1143.7%#3 | — | — | 4#1 | -74.0%#11 | — |
| MGX | $42M#12 | — | 0.4x#1 | 1.7x#3 | -51.8%#5 | -12.6%#5 | -380.9%#2 | -78.1%#7 | — | — | -47.5%#7 | — |
| ATYR | $36M#13 | — | 0.7x#4 | 189.2x#5 | -19.1%#2 | -15.8%#6 | -40856.3%#7 | -151.9%#8 | -202.0%#1 | — | -64.9%#9 | — |
| ALGS | — | — | — | — | -39.5%#3 | 81.6%#1 | -4024.9%#4 | -75.9%#6 | — | — | -50.2%#8 | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-09-18。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议